scholarly journals Review of Laser Raman Spectroscopy for Surgical Breast Cancer Detection: Stochastic Backpropagation Neural Networks

Sensors ◽  
2020 ◽  
Vol 20 (21) ◽  
pp. 6260
Author(s):  
Ragini Kothari ◽  
Yuman Fong ◽  
Michael C. Storrie-Lombardi

Laser Raman spectroscopy (LRS) is a highly specific biomolecular technique which has been shown to have the ability to distinguish malignant and normal breast tissue. This paper discusses significant advancements in the use of LRS in surgical breast cancer diagnosis, with an emphasis on statistical and machine learning strategies employed for precise, transparent and real-time analysis of Raman spectra. When combined with a variety of “machine learning” techniques LRS has been increasingly employed in oncogenic diagnostics. This paper proposes that the majority of these algorithms fail to provide the two most critical pieces of information required by the practicing surgeon: a probability that the classification of a tissue is correct, and, more importantly, the expected error in that probability. Stochastic backpropagation artificial neural networks inherently provide both pieces of information for each and every tissue site examined by LRS. If the networks are trained using both human experts and an unsupervised classification algorithm as gold standards, rapid progress can be made understanding what additional contextual data is needed to improve network classification performance. Our patients expect us to not simply have an opinion about their tumor, but to know how certain we are that we are correct. Stochastic networks can provide that information.

Cancer has been portrayed as a heterogeneous disease comprising of a wide range of subtypes. The early diagnosis of a cancer type is very important to determine the course of medical treatment required by the patient. The significance of classifying cancerous cells into benign or malignant has driven many research studies, in the biomedical and the bioinformatics field. In the past years researchers have been encouraged to use different machine learning (ML) techniques for cancer detection, as well as prediction of survivability and recurrence. What's more, ML instruments can be used to distinguish key highlights from complex datasets and uncover their significance. An assortment of these procedures, including Artificial Neural Networks (ANNs), Bayesian Networks (BNs), Random Forest Methods (RVMs) and Decision Trees (DTs) has been usually used in cancer research for the development of predictive models, resulting in successful and exact decision making. Although it is obvious that the usage of machine learning techniques can enhance our comprehension of cancer detection, progression, recurrence and survivability, a proper level of accuracy is required for these strategies to be considered in the ordinary clinical practice. The predictive models talked about here depend on different administered ML strategies and on various input features and data samples. We have used Naïve-Bayes classifier, Neural Networks method, Decision Tree and Logistic Regression algorithm to detect the type of breast cancer (Benign or Malignant) and selection of features which are more relevant for prediction. We have made a comparative study to find out the best algorithm of the above four, for prediction of cancer type. With a high level of accuracy, any of these methods can be used to predict the type of breast cancer of any particular patient


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Willie C. Zúñiga ◽  
Veronica Jones ◽  
Sarah M. Anderson ◽  
Alex Echevarria ◽  
Nathaniel L. Miller ◽  
...  

Abstract Failure to precisely distinguish malignant from healthy tissue has severe implications for breast cancer surgical outcomes. Clinical prognoses depend on precisely distinguishing healthy from malignant tissue during surgery. Laser Raman spectroscopy (LRS) has been previously shown to differentiate benign from malignant tissue in real time. However, the cost, assembly effort, and technical expertise needed for construction and implementation of the technique have prohibited widespread adoption. Recently, Raman spectrometers have been developed for non-medical uses and have become commercially available and affordable. Here we demonstrate that this current generation of Raman spectrometers can readily identify cancer in breast surgical specimens. We evaluated two commercially available, portable, near-infrared Raman systems operating at excitation wavelengths of either 785 nm or 1064 nm, collecting a total of 164 Raman spectra from cancerous, benign, and transitional regions of resected breast tissue from six patients undergoing mastectomy. The spectra were classified using standard multivariate statistical techniques. We identified a minimal set of spectral bands sufficient to reliably distinguish between healthy and malignant tissue using either the 1064 nm or 785 nm system. Our results indicate that current generation Raman spectrometers can be used as a rapid diagnostic technique distinguishing benign from malignant tissue during surgery.


Sign in / Sign up

Export Citation Format

Share Document